Anteris Technologies Global Corp. Common Stock (AVR)

• Market cap: $201M
• 1 day: -3.46%
• 5 days: -2.96%
• 1 month: 1.45%
• 3 months: 1.45%
• 6 months: 1.45%
• Year to date: 1.45%
• 1 year: 1.45%
• 5 years: 1.45%
• 10 years: 1.45%

About: Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing innovative medical devices designed to improve the quality of life for patients with aortic stenosis. Its lead product, the DurAVR THV system, represents a unique product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.